AIMS/HYPOTHESIS: γ-Aminobutyric acid (GABA) is a signalling molecule in the interstitial space in pancreatic islets. We examined the expression and function of the GABA signalling system components in human pancreatic islets from normoglycaemic and type 2 diabetic individuals. METHODS: Expression of GABA signalling system components was studied by microarray, quantitative PCR analysis, immunohistochemistry and patch-clamp experiments on cells in intact islets. Hormone release was measured from intact islets. RESULTS: The GABA signalling system was compromised in islets from type 2 diabetic individuals, where the expression of the genes encoding the α1, α2, β2 and β3 GABA(A) channel subunits was downregulated. GABA originating within the islets evoked tonic currents in the cells. The currents were enhanced by pentobarbital and inhibited by the GABA(A) receptor antagonist, SR95531. The effects of SR95531 on hormone release revealed that activation of GABA(A) channels (GABA(A) receptors) decreased both insulin and glucagon secretion. The GABA(B) receptor antagonist, CPG55845, increased insulin release in islets (16.7 mmol/l glucose) from normoglycaemic and type 2 diabetic individuals. CONCLUSIONS/ INTERPRETATION: Interstitial GABA activates GABA(A) channels and GABA(B) receptors and effectively modulates hormone release in islets from type 2 diabetic and normoglycaemic individuals.
AIMS/HYPOTHESIS: γ-Aminobutyric acid (GABA) is a signalling molecule in the interstitial space in pancreatic islets. We examined the expression and function of the GABA signalling system components in humanpancreatic islets from normoglycaemic and type 2 diabetic individuals. METHODS: Expression of GABA signalling system components was studied by microarray, quantitative PCR analysis, immunohistochemistry and patch-clamp experiments on cells in intact islets. Hormone release was measured from intact islets. RESULTS: The GABA signalling system was compromised in islets from type 2 diabetic individuals, where the expression of the genes encoding the α1, α2, β2 and β3 GABA(A) channel subunits was downregulated. GABA originating within the islets evoked tonic currents in the cells. The currents were enhanced by pentobarbital and inhibited by the GABA(A) receptor antagonist, SR95531. The effects of SR95531 on hormone release revealed that activation of GABA(A) channels (GABA(A) receptors) decreased both insulin and glucagon secretion. The GABA(B) receptor antagonist, CPG55845, increased insulin release in islets (16.7 mmol/l glucose) from normoglycaemic and type 2 diabetic individuals. CONCLUSIONS/ INTERPRETATION: Interstitial GABA activates GABA(A) channels and GABA(B) receptors and effectively modulates hormone release in islets from type 2 diabetic and normoglycaemic individuals.
Authors: Matej Oresic; Satu Simell; Marko Sysi-Aho; Kirsti Näntö-Salonen; Tuulikki Seppänen-Laakso; Vilhelmiina Parikka; Mikko Katajamaa; Anne Hekkala; Ismo Mattila; Päivi Keskinen; Laxman Yetukuri; Arja Reinikainen; Jyrki Lähde; Tapani Suortti; Jari Hakalax; Tuula Simell; Heikki Hyöty; Riitta Veijola; Jorma Ilonen; Riitta Lahesmaa; Mikael Knip; Olli Simell Journal: J Exp Med Date: 2008-12-15 Impact factor: 14.307
Authors: T M Reinbothe; S Alkayyali; E Ahlqvist; T Tuomi; B Isomaa; V Lyssenko; E Renström Journal: Diabetologia Date: 2012-11-15 Impact factor: 10.122
Authors: Rafael Arrojo e Drigo; Yusuf Ali; Juan Diez; Dinesh Kumar Srinivasan; Per-Olof Berggren; Bernhard O Boehm Journal: Diabetologia Date: 2015-07-28 Impact factor: 10.122
Authors: Hayder M Al-Kuraishy; Nawar R Hussian; Marwa S Al-Naimi; Ali I Al-Gareeb; Farah Al-Mamorri; Ali K Al-Buhadily Journal: Int J Prev Med Date: 2021-02-24